HCA Healthcare Return on Tangible Equity 2012-2026 | HCA
Current and historical return on tangible equity values for HCA Healthcare (HCA) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| HCA Healthcare Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2026-06-30 | $6.84B | $-13.21B | -51.77% |
| 2026-03-31 | $6.79B | $-12.62B | -53.82% |
| 2025-12-31 | $6.78B | $-11.92B | -56.91% |
| 2025-09-30 | $6.34B | $-11.04B | -57.47% |
| 2025-06-30 | $5.97B | $-10.23B | -58.37% |
| 2025-03-31 | $5.78B | $-9.51B | -60.78% |
| 2024-12-31 | $5.76B | $-9.01B | -63.90% |
| 2024-09-30 | $5.93B | $-8.85B | -66.99% |
| 2024-06-30 | $5.74B | $-8.91B | -64.42% |
| 2024-03-31 | $5.47B | $-9.05B | -60.47% |
| 2023-12-31 | $5.24B | $-9.21B | -56.91% |
| 2023-09-30 | $5.72B | $-9.42B | -60.67% |
| 2023-06-30 | $5.77B | $-9.67B | -59.66% |
| 2023-03-31 | $5.73B | $-10.06B | -56.98% |
| 2022-12-31 | $5.64B | $-10.00B | -56.43% |
| 2022-09-30 | $5.38B | $-9.58B | -56.11% |
| 2022-06-30 | $6.51B | $-8.81B | -73.94% |
| 2022-03-31 | $6.81B | $-7.85B | -86.76% |
| 2021-12-31 | $6.96B | $-7.09B | -98.10% |
| 2021-09-30 | $6.57B | $-6.50B | -101.06% |
| 2021-06-30 | $4.97B | $-6.49B | -76.59% |
| 2021-03-31 | $4.60B | $-6.77B | -67.94% |
| 2020-12-31 | $3.75B | $-7.56B | -49.63% |
| 2020-09-30 | $3.40B | $-8.35B | -40.70% |
| 2020-06-30 | $3.34B | $-8.94B | -37.41% |
| 2020-03-31 | $3.05B | $-9.41B | -32.38% |
| 2019-12-31 | $3.51B | $-9.69B | -36.17% |
| 2019-09-30 | $3.50B | $-10.20B | -34.29% |
| 2019-06-30 | $3.65B | $-10.67B | -34.16% |
| 2019-03-31 | $3.68B | $-11.09B | -33.20% |
| 2018-12-31 | $3.79B | $-11.46B | -33.04% |
| 2018-09-30 | $3.20B | $-11.84B | -27.00% |
| 2018-06-30 | $2.86B | $-12.08B | -23.72% |
| 2018-03-31 | $2.70B | $-12.14B | -22.25% |
| 2017-12-31 | $2.22B | $-12.19B | -18.17% |
| 2017-09-30 | $2.66B | $-12.18B | -21.86% |
| 2017-06-30 | $2.85B | $-12.29B | -23.23% |
| 2017-03-31 | $2.86B | $-12.62B | -22.62% |
| 2016-12-31 | $2.89B | $-12.77B | -22.62% |
| 2016-09-30 | $2.55B | $-12.88B | -19.81% |
| 2016-06-30 | $2.38B | $-12.76B | -18.68% |
| 2016-03-31 | $2.23B | $-12.57B | -17.76% |
| 2015-12-31 | $2.13B | $-12.55B | -16.96% |
| 2015-09-30 | $2.07B | $-12.59B | -16.48% |
| 2015-06-30 | $2.14B | $-12.48B | -17.18% |
| 2015-03-31 | $2.12B | $-12.49B | -16.96% |
| 2014-12-31 | $1.88B | $-12.43B | -15.09% |
| 2014-09-30 | $1.77B | $-12.41B | -14.28% |
| 2014-06-30 | $1.62B | $-12.65B | -12.80% |
| 2014-03-31 | $1.56B | $-12.78B | -12.20% |
| 2013-12-31 | $1.56B | $-13.07B | -11.91% |
| 2013-09-30 | $1.45B | $-13.33B | -10.85% |
| 2013-06-30 | $1.44B | $-13.12B | -10.98% |
| 2013-03-31 | $1.41B | $-12.96B | -10.87% |
| 2012-12-31 | $1.61B | $-12.75B | -12.59% |
| 2012-09-30 | $3.23B | $-12.35B | -26.13% |
| 2012-06-30 | $2.93B | $-12.28B | -23.83% |
| 2012-03-31 | $2.77B | $-11.75B | -23.53% |
| 2011-12-31 | $2.47B | $-11.19B | -22.02% |
| 2011-09-30 | $0.81B | $-11.50B | -7.07% |
| 2011-06-30 | $1.00B | $-11.52B | -8.64% |
| 2011-03-31 | $1.06B | $-11.98B | -8.84% |
| 2010-12-31 | $1.21B | $-12.32B | -9.80% |
| 2010-09-30 | $1.14B | $-11.59B | -9.84% |
| 2010-06-30 | $1.09B | $-11.35B | -9.63% |
| 2010-03-31 | $1.08B | $-11.09B | -9.75% |
| 2009-12-31 | $1.05B | $-10.99B | -9.59% |
| 2009-09-30 | $1.11B | $-11.31B | -9.85% |
| 2009-06-30 | $1.00B | $-11.78B | -8.53% |
| 2009-03-31 | $0.86B | $-12.21B | -7.07% |
| 2008-12-31 | $0.67B | $-12.64B | -5.32% |
| 2008-09-30 | $0.68B | $-12.97B | -5.20% |
| 2008-06-30 | $0.89B | $-13.13B | -6.77% |
| 2008-03-31 | $0.86B | $-13.31B | -6.49% |
| 2007-12-31 | $0.87B | $-13.46B | -6.50% |
| 2007-09-30 | $0.72B | $-13.66B | -5.26% |
| 2007-06-30 | $0.66B | $-9.70B | -6.78% |
| 2007-03-31 | $0.84B | $-5.77B | -14.50% |
| 2006-12-31 | $1.04B | $-1.85B | -55.99% |
| 2006-09-30 | $1.24B | $2.20B | 56.25% |
| 2006-06-30 | $1.28B | $2.52B | 50.84% |
| 2006-03-31 | $1.39B | $2.85B | 48.83% |
| 2005-12-31 | $1.42B | $3.05B | 46.70% |
| 2005-09-30 | $1.42B | $2.96B | 48.06% |
| 2005-06-30 | $1.37B | $3.03B | 45.09% |
| 2005-03-31 | $1.32B | $3.12B | 42.12% |
| 2004-12-31 | $1.25B | $3.36B | 37.07% |
| 2004-09-30 | $1.24B | $3.83B | 32.43% |
| 2004-06-30 | $1.32B | $3.73B | 35.41% |
| 2004-03-31 | $1.21B | $3.64B | 33.22% |
| 2003-12-31 | $1.33B | $3.72B | 35.78% |
| 2003-09-30 | $0.91B | $3.72B | 24.55% |
| 2003-06-30 | $0.81B | $3.75B | 21.55% |
| 2003-03-31 | $0.92B | $3.81B | 24.05% |
| 2002-12-31 | $0.83B | $3.59B | 23.20% |
| 2002-09-30 | $0.98B | $3.36B | 29.06% |
| 2002-06-30 | $1.03B | $3.15B | 32.81% |
| 2002-03-31 | $0.95B | $2.88B | 32.81% |
| 2001-12-31 | $0.89B | $2.68B | 33.02% |
| 2001-09-30 | $0.87B | $2.55B | 33.94% |
| 2001-06-30 | $0.78B | $1.83B | 42.82% |
| 2001-03-31 | $0.25B | $1.16B | 21.50% |
| 2000-12-31 | $0.22B | $0.56B | 38.93% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $91.758B | $75.600B |
| HCA Healthcare Inc. is a provider of healthcare services comprising hospitals and ambulatory sites of care including surgery centers, freestanding ERs, urgent care centers and physician clinics. HCA Healthcare Inc., formerly known as HCA HOLDINGS, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.177B | 25.78 |
| CVS Health (CVS) | United States | $120.850B | 12.05 |
| Elevance Health (ELV) | United States | $90.552B | 14.21 |
| Cencora (COR) | United States | $61.693B | 18.85 |
| Natera (NTRA) | United States | $50.563B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.274B | 18.52 |
| Viatris (VTRS) | United States | $19.124B | 6.61 |
| Medpace Holdings (MEDP) | United States | $17.319B | 36.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.369B | 0.00 |
| DiDi Global (DIDIY) | China | $16.046B | 176.00 |
| Revvity (RVTY) | United States | $15.643B | 26.20 |
| Solventum (SOLV) | United States | $15.330B | 12.69 |
| ICON (ICLR) | Ireland | $13.204B | 17.94 |
| Charles River Laboratories (CRL) | United States | $13.027B | 27.56 |
| BrightSpring Health Services (BTSG) | United States | $11.642B | 40.03 |
| Avantor (AVTR) | United States | $10.443B | 18.83 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.054B | 79.17 |
| HealthEquity (HQY) | United States | $7.983B | 26.01 |
| Sonic Healthcare (SKHHY) | Australia | $6.771B | 0.00 |
| PACS (PACS) | United States | $6.662B | 22.39 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.327B | 0.00 |
| MiniMed (MMED) | United States | $6.193B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.157B | 23.28 |
| Sotera Health (SHC) | United States | $5.416B | 22.33 |
| Concentras Parent (CON) | United States | $4.542B | 22.40 |
| Organon (OGN) | United States | $3.587B | 4.55 |
| GeneDx Holdings (WGS) | United States | $2.822B | 262.89 |
| CareDx (CDNA) | United States | $2.723B | 309.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.169B | 12.71 |
| Alignment Healthcare (ALHC) | United States | $2.151B | 54.58 |
| Establishment Labs Holdings (ESTA) | United States | $2.130B | 0.00 |
| Progyny (PGNY) | United States | $2.130B | 30.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.912B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.907B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.787B | 68.25 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.573B | 0.00 |
| Agilon Health (AGL) | United States | $1.547B | 0.00 |
| Ardent Health (ARDT) | United States | $1.508B | 8.62 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Nutex Health (NUTX) | United States | $1.475B | 8.45 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.204B | 245.88 |
| GoodRx Holdings (GDRX) | United States | $1.196B | 23.27 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| CryoPort (CYRX) | United States | $0.826B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.688B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.472B | 9.77 |
| Strata Critical Medical (SRTA) | United States | $0.468B | 0.00 |
| Forward Industries (FWDI) | United States | $0.449B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.382B | 5.55 |
| Shoulder Innovations (SI) | United States | $0.374B | 0.00 |
| Biodesix (BDSX) | United States | $0.292B | 0.00 |
| Embecta (EMBC) | United States | $0.288B | 2.50 |
| So-Young (SY) | China | $0.276B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.098B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.068B | 8.06 |
| Tevogen (TVGN) | United States | $0.050B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.008B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |